Admission ST-segment elevation in lead aVR as the factor improving complex risk stratification in acute coronary

Filip M Szymański1, Marcin Grabowski, Krzysztof J Filipiak

  • 1First Department of Cardiology, The Medical University of Warsaw, 02-097 Warsaw, Poland. f.szymanski@post.pl

Insights

ST elevation in lead aVR (aVR(+)) on initial ECG is a strong predictor of 30-day mortality in unstable angina/non-ST-elevation myocardial infarction (UA/NSTEMI) patients. This finding is particularly important for identifying high-risk individuals within low-risk groups.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Diagnostic Tools

Background:

  • Unstable angina/non-ST-elevation myocardial infarction (UA/NSTEMI) is a critical cardiovascular condition.
  • Accurate prognostic markers are essential for risk stratification and patient management.
  • The prognostic value of ST elevation in lead aVR (aVR(+)) in UA/NSTEMI requires further elucidation.

Purpose of the Study:

  • To analyze the prognostic significance of aVR(+) on admission ECG in UA/NSTEMI patients.
  • To evaluate the combined prognostic value of aVR(+) with clinical variables and TIMI risk score.
  • To determine if aVR(+) provides additional prognostic information in low- and intermediate-risk UA/NSTEMI patients.

Main Methods:

  • Retrospective analysis of admission ECGs in 205 consecutive UA/NSTEMI patients.
  • Evaluation of ST elevation in lead aVR (aVR(+)) > 0.5 mm.
  • Multivariate analysis to assess independent predictors of 30-day mortality.
  • Stratification by clinical factors and Thrombolysis in Myocardial Infarction (TIMI) risk score.

Main Results:

  • Admission aVR(+) was a strong and independent predictor of 30-day mortality in UA/NSTEMI.
  • Mortality significantly increased with the severity of aVR(+).
  • Patients with aVR(+) exhibited higher death rates, even within predefined low-risk clinical groups and TIMI risk score categories.

Conclusions:

  • aVR(+) on admission ECG possesses significant prognostic value in UA/NSTEMI.
  • aVR(+) offers incremental prognostic information beyond conventional risk factors, especially in low- and intermediate-risk patients.
  • Routine assessment of aVR(+) may enhance risk stratification in UA/NSTEMI management.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...